Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Abbott and Celera form cancer therapeutics collaboration

July 9, 2004

GOG submits IND for Xyotax study in ovarian cancer

July 9, 2004

U.S. phase I trial of Exherin cleared to begin

July 9, 2004

Chiron acquires Sagres Discovery

July 9, 2004

Modulators of tyrosine kinase-mediated signal transduction disclosed in patent

July 8, 2004

Pharmion launches Vidaza

July 8, 2004

NeoRx files IND for phase II study of STR in metastatic breast cancer

July 8, 2004

sBLA filed for Bexxar

July 8, 2004

HKI-272 shows promise in the treatment of HER-2-positive tumors

July 7, 2004

Tropical plant derivative induces mitochondria-dependent apoptosis in vitro

July 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...